Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 7.43 | 37.90 |
PEG Ratio (TTM) | 0.80 | 5.33 |
P/S Ratio (TTM) | 1.26 | 66.51 |
P/B Ratio (TTM) | 1.19 | 72.67 |
P/FCF Ratio (TTM) | 3.42 | 83.40 |
Price to 5YR AVG Earnings Ratio | 6.24 | 13.84 |
Price to 5YR AVG FCF Ratio | -21.04 | 46.20 |
Profitability (45%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.72% | 648.99% |
ROE (TTM) | 17.50% | 10.18% |
Net Profit Margin (TTM) | 16.02% | -11.93% |
ROIC 5YR AVG | 4.46% | 15.72% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.58% | 39.41% | 19.12% |
Revenue | 17.27% | 31.94% | 41.54% |
Net Income | 15.47% | 49.10% | 25.23% |
Cash Flow | -87.18% | 264.19% | 121.26% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 26.40 | 5.01 |
Quick Ratio (TTM) | 26.40 | 4.44 |
D/E Ratio (TTM) | 4.61 | 0.85 |
Interest Coverage (TTM) | 1.49 | 8.93 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.61 | 6.21 |
LTL to 5YR AVG FCF | -65.30 | 7.60 |
Shares Outstanding Growth 5YR AVG | 5.16% | 3.56% |